Complications of Chronic Pancreatitis

  • John Petersen
  • Chris E. Forsmark
Part of the Clinical Gastroenterology book series (CG)

Abstract

Chronic pancreatitis (CP) is a disease characterized by the progressive and irreversible loss of pancreatic structure and exocrine and endocrine function. Various complications can develop that require medical evaluation and intervention. The vast majority of patients with CP have the disease because of alcohol intake, and these patients often develop symptoms related to alcohol abuse, as well as problems directly attributable to pancreatitis. CP is burdened with numerous complications,but only a fraction (∼20%) is directly the result of pancreatitis or one of its direct effects. Most patients with CP die of respiratory and other digestive malignancies, coexistent chronic liver disease, cardiovascular causes, or postoperative complications. This chapter examines some of the more unusual complications of CP, including pancreatic diabetes, nutritional issues, pleuropulmonary influences, panniculitis and arthritis, gastroparesis, venous thromboses, biliary and duodenal obstruction, pancreatic fistulae, and pancreatic malignancy. (Exocrine insufficiency is discussed in Chapter 16.)

Keywords

Zinc Arthritis Hepatitis Codon Osteoporosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Apte MV, Keogh W, Wilson JS. Chronic pancreatitis: Complications and management. J Clin Gastroenterol 1999; 29: 225–240.PubMedCrossRefGoogle Scholar
  2. 2.
    Layer P. The different courses of early-and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481–1487.PubMedGoogle Scholar
  3. 3.
    Lankisch PG. Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 1993; 54: 148–155.PubMedCrossRefGoogle Scholar
  4. 4.
    Kloppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas 1993; 8: 659–670.PubMedGoogle Scholar
  5. 5.
    Malka D, Hammel P, Sauvenet A, et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 2000; 119: 1324–1332.PubMedCrossRefGoogle Scholar
  6. 6.
    Wakasugi H, Funakoshi A, Iguchi H. Clinical assessment of pancreatic diabetes caused by chronic pancreatitis. J Gastroenterol 1998; 33: 254–259.PubMedCrossRefGoogle Scholar
  7. 7.
    Marks V. The enteroinsular axis. J Clin Path 1980; 33: 38–42.Google Scholar
  8. 8.
    Ebert R, Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatic steatorrhea following enzyme substitution. Diabetologica 1980; 19: 198–204.CrossRefGoogle Scholar
  9. 9.
    Larsen S, Hilsted J, Phillipsen EK, et al. Glucose counter-regulation in diabetes secondary to chronic pancreatitis. Metabolism 1990; 39: 138–143.PubMedCrossRefGoogle Scholar
  10. 10.
    Sjoberg RJ, Kidd GS. Pancreatic diabetes mellitus. Diabetes Care 1989; 12: 715–724.PubMedCrossRefGoogle Scholar
  11. 11.
    Quilliot D, Dousset B, Guerci B, et al. Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitis. Pancreas 2001; 22: 299–306.PubMedCrossRefGoogle Scholar
  12. 12.
    Couet C, Genton P, Pointel JP, et al. The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus. Diabetes Care 1985; 8: 323–328.PubMedCrossRefGoogle Scholar
  13. 13.
    Icks A, Haastert B, Giani G, Rathman W. Low fecal elastase-1 in type I diabetes mellitus. Z Gastroenterol 2001; 39: 823–830.PubMedCrossRefGoogle Scholar
  14. 14.
    Hardt PD, Krauss A, Bretz L, et al. Pancreatic exocrine function in patients with Type 1 and 2 diabetes mellitus. Acta Diabetol 2000; 37: 105–110.PubMedCrossRefGoogle Scholar
  15. 15.
    Hardt PD, Killinger A, Nalop J, et al. Chronic pancreatitis and diabetes mellitus Aretrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin dependent diabetes mellitus. Pancreatology 2002; 2: 30–33.PubMedCrossRefGoogle Scholar
  16. 16.
    Hebuterne X, Hastier P, Peroux J-L, et al. Resting energy expenditure in patients with chronic pancreatitis. Dig Dis Sci 1996; 41: 533–539.PubMedCrossRefGoogle Scholar
  17. 17.
    Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin 1999; 15: 47–52.PubMedCrossRefGoogle Scholar
  18. 18.
    Haaber AB, Rosenfalck AM, Hansen B, et al. Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Int J Pancreatol 2000; 27: 21–27.PubMedGoogle Scholar
  19. 19.
    Forsmark CE, Grendell JH. Complications of pancreatitis. Semin Gastrointest Dis 1991; 2: 165–176.Google Scholar
  20. 20.
    Gomez-Cerezo J, Barbado Cano A, Suarez I, et al. Pancreatic ascites: study of therapeutic options by analysis of case reports and case series between the years 1975 and 2000. Am J Gastroenterol 2003; 98: 568–577.PubMedGoogle Scholar
  21. 21.
    Bedingfield JA, Anderson MC. Pancreatopleural fistula. Pancreas 1986; 1: 283–290.PubMedCrossRefGoogle Scholar
  22. 22.
    Rockey DC, Cello JP. Pancreaticopleural fistula. Report of 7 patients and a review of the literature. Medicine 1990; 69: 332–344.PubMedCrossRefGoogle Scholar
  23. 23.
    Tannenbaum H, Anderson LG, Schur PH. Polyarthritis, subcutaneous nodules, and pancreatic disease. J Rheum 1975; 2: 14–20.Google Scholar
  24. 24.
    Dahl PR, Su WPD, Cullimore KC, Dicken CH. Pancreatic panniculitis. J Am Acad Derm 1995; 33: 415–417.Google Scholar
  25. 25.
    Mehringer S, Vogt T, Tabusch H-C, et al. Treatments of panniculitis in chronic pancreatitis by interventional endoscopy following extracorporeal lithotripsy. Gastrointest Endosc 2001; 53: 234–238.CrossRefGoogle Scholar
  26. 26.
    Chowdhury RC, Forsmark CE, Davis RH, et al. Prevalence of gastroparesis in patients with chronic pancreatitis. Pancreas 2003; 26: 235–238.PubMedCrossRefGoogle Scholar
  27. 27.
    Layer P, Vonderohe MR, Holst JJ, et al. Altered postprandial motility in chronic pancreatitis: Role of malabsorption. Gastroenterology 1997; 112: 1624–1634.PubMedCrossRefGoogle Scholar
  28. 28.
    Vu MK, Vecht J, Eddes EH, et al. Antroduodenal motility in chronic pancreatitis: are abnormalities related to exocrine insufficiency? Am J Physiol 2000; 278: G 458–466.Google Scholar
  29. 29.
    Bernades P, Baetz A, Levy P, et al. Splenic and portal vein obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical service of 266 patients. Dig Dis Sci 1992; 37: 340–346.PubMedCrossRefGoogle Scholar
  30. 30.
    Forsmark CE, Wilcox CM, Grendell JG. Endoscopy-negative upper gastrointestinal hemorrhage in a patient with chronic pancreatitis. Gastroenterology 1992; 102: 320–329.PubMedGoogle Scholar
  31. 31.
    Saforkas GH, Sarr MG, Farley DR, et al. The significance of sinistrial portal hypertension complicating chronic pancreatitis. Am J Surg 2000; 179: 129–133CrossRefGoogle Scholar
  32. 32.
    Fogartie JA, Adams DB, Vujic I, et al. Splanchnic venous obstruction. A complication of chronic pancreatitis. Am Surg 1989; 55: 191–197.PubMedGoogle Scholar
  33. 33.
    Warshaw AL, Rattner DW. Facts and fallacies of common bile duct obstruction by pancreatic pseudocysts. Ann Surg 1979; 192: 33–37.CrossRefGoogle Scholar
  34. 34.
    Rattner DW, Warshaw AL. Venous, biliary, and duodenal obstruction in chronic pancreatitis. Hepatogastroenterol 1990; 37: 301–306.Google Scholar
  35. 35.
    Lesur G, Levy P, Flejou JF, et al. Factors predictive of liver histological appearance in chronic alcoholic pancreatitis with common bile duct stenosis and increased serum alkaline phosphatase. Hepatology 1993; 18: 1078–1081.PubMedGoogle Scholar
  36. 36.
    Hammel P, Couvelard A, O’Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001; 344: 418–423.PubMedCrossRefGoogle Scholar
  37. 37.
    Schlosser W, Siech M, Gorich J, et al. Common bile duct stenosis in complicated chronic pancreatitis. Scand J Gastroenterol 2001; 36: 214–219.PubMedGoogle Scholar
  38. 38.
    Schlosser W, Poch B, Beger HG. Duodenum-preserving pancreatic head resection leads to relief of common bile duct stenosis. Am J Surg 2002; 183: 37–41.PubMedCrossRefGoogle Scholar
  39. 39.
    Ng C, Huibregtse K. The role of endoscopic therapy in chronic pancreatitis-induced common bile duct stricture. Gastrointest Endosc Clin N Am 1998; 8: 181–193.PubMedGoogle Scholar
  40. 40.
    Kiehne K, Folsch UR, Nitsche R. High complication rate of bile duct stents in patients with chronic alcoholic pancreatitis due to noncompliance. Endoscopy 2000; 32: 377–380.PubMedCrossRefGoogle Scholar
  41. 41.
    Eickhoff A, Jakobs R, Leonhardt A, et al. Endoscopic stenting for common bile duct stenoses in chronic pancreatitis: results and impact on long term outcome. Eur J Gastroenterol Hepatol 2001; 13: 1161–1167.PubMedCrossRefGoogle Scholar
  42. 42.
    Kahl S, Zimmerman S, Glasbrenner B, et al. Treatment of benign biliary strictures in chronic pancreatitis by self-expandable metal stents. Dig Dis 2002; 20: 199–203.PubMedCrossRefGoogle Scholar
  43. 43.
    Izbicki JR, Bloechle C, Knoefel WT, et al. Complications of adjacent organs in chronic pancreatitis managed by duodenum preserving resection of the head of the pancreas. Br J Surg 1994; 81: 1351–1355.PubMedCrossRefGoogle Scholar
  44. 44.
    Nassif T, Pratt F, Meduri B, et al. Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study Endoscopy 2003; 35: 483–489.PubMedCrossRefGoogle Scholar
  45. 45.
    Stabile BE, Wilson SE, DeBas HT. Reduced mortality from pseudocysts and pseudoaneurysms caused by pancreatitis. Arch Surg 1983; 118: 45–51.PubMedGoogle Scholar
  46. 46.
    Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993; 328: 1433–1437.PubMedCrossRefGoogle Scholar
  47. 47.
    Lowenfels AB, Maissonnueve P, Cavalini G, et al. Prognosis of chronic pancreatitis: An international multicenter study. Am J Gastroenterol 1994; 89: 1467–1471.PubMedGoogle Scholar
  48. 48.
    Lowenfels AB, Maissonnueve P, DiMagno EP, et al., for the International Hereditary Pancreatitis Study Group. Hereditary pancreatitis and the risk of pancreatic carcinoma. J Natl Cancer Inst 1997; 89: 442–446.PubMedCrossRefGoogle Scholar
  49. 49.
    Chari ST, Mohan V, Pitchumoni CS, et al. Risk of pancreatic carcinoma in tropical calcifying pancreatitis. Pancreas 1994; 9: 62–66.PubMedCrossRefGoogle Scholar
  50. 50.
    Perez-Stable EJ, Herrera B, Jacobs P III, et al. Nicotine metabolism and intake in black and white smokers. JAMA 1998; 280: 152–156.PubMedCrossRefGoogle Scholar
  51. 51.
    Bansal P, Sonnenberg A. Pancreatitis as a risk factor for pancreatic carcinoma. Gastroenterology 1995; 109: 247–241.PubMedCrossRefGoogle Scholar
  52. 52.
    Everhar J, Wrigh D. Diabetes mellitus as a risk factor for pancreatic carcinoma. JAMA 1995; 273: 1605–1609.CrossRefGoogle Scholar
  53. 53.
    Gress F, Gottlied K, Sherman S, Lehman G. Endoscopic ultrasonography guided fine needle aspiration biopsy of suspected pancreatic carcinoma. Ann Intern Med 2001; 134: 459–464.PubMedGoogle Scholar
  54. 54.
    Jowell PS. Assessment of pancreatic duct strictures. Gastrointest Endosc Clin N Am 1995; 5: 125–143.PubMedGoogle Scholar
  55. 55.
    Yusuf TE, Bhutani MS. Differentiating pancreatic cancer from pseudotumorous chronic pancreatitis. Curr Gastroenterol Rep 2002; 4: 135–139.PubMedCrossRefGoogle Scholar
  56. 56.
    Steinberg W. Clinical utility of the CA 19-9 tumor associated antigen. Am J Gastroenterol 1990; 85: 350–355.PubMedGoogle Scholar
  57. 57.
    Imdahl A, Nitzsche E, Krautmann F, et al. Evaluation of PET with FDG for the differentiation of chronic pancreatitis and pancreatic carcinoma. Br J Surg 1999; 86: 194–199.PubMedCrossRefGoogle Scholar
  58. 58.
    Schneider G, Schmid RM. Genetic alterations in pancreatic carcinoma. Mol Cancer 2003; 2: 15, 1–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Andrianifahanana M, Moniaux N, Schmied BM, et al. Mucin (MUC) gene expression in human pancreatic carcinoma and chronic pancreatitis. A potential role of MUC 4 as a tumor marker of diagnostic significance. Clin Cancer Res 2001; 7: 4033–4040.PubMedGoogle Scholar
  60. 60.
    Pugliese V, Puji N, Saccomanno S, et al. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic carcinoma: Cytologic studies of k-ras-2 codon 12 molecular analysis in 47 patients. Gastrointest Endosc 2001; 54: 595–599.PubMedCrossRefGoogle Scholar
  61. 61.
    Bueltler P, Conejo-Garcia JR, Lehman G, et al. Real-time quantitative PCR of telomerase mRNA is useful in differentiation of benign and malignant pancreatic disorders. Pancreas 2001; 22: 337–340.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Authors and Affiliations

  • John Petersen
    • 1
  • Chris E. Forsmark
    • 1
  1. 1.Division of Gastroenterology, Hepatology, and NutritionUniversity of Florida College of MedicineGainesville

Personalised recommendations